Haicheung pharmaceutical industry proposed to increase 25 million shares 25th

Haicheung Pharmaceutical (002099) February 24 evening Notice, the company intends to include the controlling shareholder Rou and general manager Li Weiking, including not more than 10 of the specific objects of the non-public offering of no more than 25 million shares, the issue price is not less than 20.92 yuan/share. The collection of funds will be used for the annual output of 400 tons of carbon penicillium antibiotics key intermediates 4-AA Technical renovation project, an annual output of 1 billion tablets (tablets) oral solid preparation project, annual output of 4 tons of sterile raw materials and 5 million aseptic powder injection project, the company also published annual report shows that 2010-Year total operating income of 1.074 billion yuan, an increase of 20.29% per cent, the net profit of the listed company shareholders 85.6282 million yuan, the year-on-year increase of 182.59%;　　The company intends to distribute a cash dividend of $2 per 10 shares to all shareholders. Company shares February 25, the latest closing price of 25.15 yuan.